[1. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Eng J Med. 1981; 304: 1135.10.1056/NEJM1981050730419047012619]Search in Google Scholar
[2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Eng J Med. 2002; 346: 995-1008.10.1056/NEJMra01050111919310]Search in Google Scholar
[3. Satoh T, Pandey JP, Okazaki Y et al. Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura. Br J Haematol. 2004; 124: 796-801.10.1111/j.1365-2141.2004.04843.x15009068]Search in Google Scholar
[4. Foster CB, et al. Polymorphisms in inflammatory cytokines and Fcγ receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol. 2001; 1134: 596-599.10.1046/j.1365-2141.2001.02807.x11380443]Search in Google Scholar
[5. Rocha AM, DeSouza C, Rocha GA, De Mello FF, Saraiva IS, Clementino NC, Marino MC, Queiroz DM. IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopenia. Br J Haematolol. 2010; 150: 679-84.10.1111/j.1365-2141.2010.08318.x20626741]Search in Google Scholar
[6. Zhao H, Du W, Gu D, Wang D, Xue F, Ge J, Sui T, Yang R. DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population. Acta Haematol. 2009; 122: 31-5.10.1159/00023561619696477]Search in Google Scholar
[7. Breunis WB, van Mirre E, Bruin M, Geissler J, Boer M, Peters M, Roos D, Haas M, Koene HR, Kuijpers TW. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood. 2008; 111: 1029-1038.10.1182/blood-2007-03-07991317827395]Search in Google Scholar
[8. Pavkovic M, Georgievski B, Cevreska L, Spiroski M, Efremov DG. CTLA-4 Exon 1 Polymorphism in patients with autoimmune blood disorders. Am J Hematol. 2003; 72: 147-9.10.1002/ajh.1027812555221]Search in Google Scholar
[9. Li H, Ge J, Zhao H, Du W, Xu J, Sui T, Ma L, Zhou Z, Qi A, Yang R. Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with idiopathic thrombocytopenic purpura in a Chinese population. Platelets. 2011; 22: 37-42.10.3109/09537104.2010.52160121034161]Search in Google Scholar
[10. Kuwana M, Kaburaki J, Pandey JP, Murata M, Kawakami Y, Inoko H, Ikeda Y. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with antiplatelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens. 2000; 56: 337-343.10.1034/j.1399-0039.2000.560405.x11098933]Search in Google Scholar
[11. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998; 352: 878.10.1016/S0140-6736(05)60004-9]Search in Google Scholar
[12. Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol. 2006; 84: 309-15.10.1532/IJH97.06188]Search in Google Scholar
[13. Satoh T, Pandey JP, Okazaki Y, et al. Single nucleotide polymorphisms of interleukin-1β associated with Helicobacter pylori infection in immune thrombocytopenic purpura. Tissue Antigens. 2009; 73: 353-357.10.1111/j.1399-0039.2009.01214.x]Search in Google Scholar
[14. George JE, Woolf SH, Raskob GE, Wasser JS, Alderot LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Oker-bloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura:a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88: 3-40.10.1182/blood.V88.1.3.3]Search in Google Scholar
[15. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113: 2386-2393.10.1182/blood-2008-07-162503]Search in Google Scholar
[16. Giovine FS, Takhsh E, Blakemore AIF, Duff GW. Single base polymorphism at -511 in the human interleukine-1β gene (IL1β). Hum Mol Genetics. 1992; 1: 450.10.1093/hmg/1.6.450]Search in Google Scholar
[17. Lee EB, Kim JY, Lee YJ, Park MH, Song YW. TNF and TNF receptor polymorphisms in Korean Be-chet’s disease patients. Hum Immunol. 2003; 64: 614-620.10.1016/S0198-8859(03)00057-0]Search in Google Scholar
[18. Kornman KS, Crane A, Wang HY, di Giovani FS, Newman MG, Pirk FW, Wilson TG., Higginbottom FL, Duff GW. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontal. 1997; 24: 72-77.10.1111/j.1600-051X.1997.tb01187.x]Search in Google Scholar
[19. Bettinotti MP, Hartung K, Deicher H, et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics. 1993; 37: 449-45410.1007/BF002224698436420]Search in Google Scholar
[20. Badenhoop, Schwarz G, Schleusener H, et al. Tumor necrosis factor beta gene polymorphisms in Graves’ disease. J Clin End Metab. 1992; 74: 287-291.]Search in Google Scholar
[21. Vandevyver C, Raus P, Stinisen P, et al. Polymorphism of the tumor necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur J Immunogenet. 1994; 21: 377-382.10.1111/j.1744-313X.1994.tb00208.x]Search in Google Scholar
[22. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991; 173: 209-219.10.1084/jem.173.1.20921187571670638]Search in Google Scholar
[23. Moffatt MF, Cookson WO. Tumor necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-554.10.1093/hmg/6.4.5519097957]Search in Google Scholar
[24. Kehrl JH, Alvarez-Mon M, Delsing GA, Fauci AS. Lymphotoxin is an important T cellderived growth factor for human B cell. Science. 1987; 238: 114-1146.10.1126/science.35005123500512]Search in Google Scholar
[25. Steffen M, Ottmann OG, Moore MA. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J Immunol. 1988; 140: 2621-2624. 10.4049/jimmunol.140.8.2621]Search in Google Scholar